businessJPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win Author4 hours ago01 mins JPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win Source link Post navigation Previous: How to build and manage an integrated patient pathwayNext: A space has opened up in British politics Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.